Profile data is unavailable for this security.
About the company
Renalytix plc is a United Kingdom-based company, which is engaged in the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The Company is engaged in a field of bioprognosis for kidney health. The Company has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. The Company’s lead product, KidneyIntelX platform, is designed to scale across kidney disease conditions beyond diabetic kidney disease. It is evaluating a range of indications in chronic kidney disease, cardio-renal disease, chronic kidney disease in diverse populations and COVID-related kidney disease. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
- Revenue in USD (TTM)2.22m
- Net income in USD-37.49m
- Incorporated2018
- Employees102.00
- LocationRenalytix PLCFinsgate, 5-7 Cranwood StreetLONDON EC1V 9EEUnited KingdomGBR
- Phone+44 292 071 0570
- Websitehttps://renalytix.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LiveCare Inc | 0.00 | -2.34m | 16.99m | -- | -- | 6.43 | -- | -- | -0.1411 | -0.1411 | 0.00 | 0.0463 | 0.00 | -- | -- | -- | -424.83 | -- | -550.62 | -- | -- | -- | -- | -- | -- | -8.18 | 0.1888 | -- | -- | -- | -344.86 | -- | -- | -- |
| Trinity Biotech plc (ADR) | 58.65m | -22.29m | 18.19m | 380.00 | -- | -- | -- | 0.3102 | -2.74 | -2.74 | 7.23 | -19.24 | 0.7052 | 1.69 | 3.74 | 154,347.40 | -26.80 | -20.30 | -35.44 | -29.54 | 34.28 | 39.92 | -38.01 | -29.86 | 0.8936 | -2.16 | 1.46 | -- | -9.10 | -10.15 | 15.41 | -- | -31.08 | -- |
| PAVmed Inc | 3.83m | -67.35m | 18.52m | 107.00 | -- | -- | -- | 4.84 | -8.17 | -8.17 | 0.4595 | -7.74 | 0.0823 | -- | 29.45 | 35,785.05 | -155.93 | -154.56 | -- | -1,152.82 | -77.59 | -- | -1,895.64 | -8,764.89 | 0.5529 | -8.16 | 1.74 | -- | 550.40 | -- | 25.76 | -- | 55.51 | -- |
| Autonomix Medical Inc | -100.00bn | -100.00bn | 18.89m | 5.00 | -- | 2.18 | -- | -- | -- | -- | -- | 0.2749 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.1647 | -- | -- | -- | -674.99 | -- | -- | -- |
| Beyond Air Inc | 1.78m | -58.35m | 19.47m | 107.00 | -- | 1.04 | -- | 10.92 | -1.65 | -1.65 | 0.0485 | 0.3514 | 0.0298 | 1.70 | 6.87 | 16,663.55 | -104.22 | -78.25 | -137.64 | -99.91 | -78.30 | -- | -3,493.78 | -6,152.99 | 2.42 | -38.11 | 0.4666 | -- | -- | -31.57 | -7.93 | -- | 152.05 | -- |
| SANUWAVE Health Inc | 24.90m | -3.43m | 20.08m | 31.00 | -- | -- | -- | 0.8067 | -0.0095 | -0.0095 | 0.0218 | -0.0335 | 1.24 | 3.90 | 8.34 | 803,064.50 | -17.07 | -136.54 | -- | -- | 71.57 | 69.13 | -13.79 | -189.60 | 0.0999 | 0.1199 | -- | -- | 21.84 | 61.61 | -150.72 | -- | -- | -- |
| SeaStar Medical Holding Corp | 0.00 | -33.23m | 20.52m | 12.00 | -- | -- | -- | -- | -21.41 | -21.41 | 0.00 | -2.14 | 0.00 | -- | -- | 0.00 | -1,145.80 | -- | -- | -- | -- | -- | -- | -- | -- | -9.51 | -- | -- | -- | -- | -115.19 | -- | -- | -- |
| Renalytix PLC (ADR) | 2.22m | -37.49m | 20.68m | 102.00 | -- | -- | -- | 9.31 | -0.7843 | -0.7843 | 0.0463 | -0.1853 | 0.0915 | -- | 3.41 | -- | -154.36 | -102.16 | -396.70 | -124.78 | -1.58 | -- | -1,687.80 | -2,268.11 | -- | -8.74 | -- | -- | 14.58 | -- | -0.7311 | -- | -- | -- |
| Neuraxis Inc | 2.27m | -15.26m | 21.55m | 19.00 | -- | -- | -- | 9.51 | -3.09 | -3.09 | 0.4039 | -0.7686 | 1.09 | 6.63 | 11.80 | 119,318.90 | -731.17 | -- | -- | -- | 87.29 | -- | -672.94 | -- | 0.2724 | -19.01 | -- | -- | -8.37 | -- | -163.78 | -- | -- | -- |
| Neuronetics Inc | 72.07m | -32.47m | 22.15m | 203.00 | -- | 1.17 | -- | 0.3073 | -1.10 | -1.10 | 2.45 | 0.6433 | 0.7309 | 2.31 | 4.76 | 355,000.00 | -32.93 | -28.02 | -42.47 | -34.73 | 75.91 | 75.73 | -45.06 | -51.04 | 2.37 | -3.92 | 0.755 | -- | 9.42 | 6.22 | 18.76 | -- | 18.57 | -- |
| Inspira Technologies Oxy BHN Ltd | 0.00 | -11.29m | 22.31m | 37.00 | -- | 3.79 | -- | -- | -0.9549 | -0.9549 | 0.00 | 0.3666 | 0.00 | -- | -- | 0.00 | -88.60 | -114.98 | -108.36 | -159.56 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 24.64 | -- | -- | -- |
| Spectral AI Inc | 22.53m | -20.24m | 22.71m | 78.00 | -- | -- | -- | 1.01 | -1.48 | -1.48 | 1.55 | -0.2422 | 1.68 | -- | 11.54 | 288,859.00 | -150.54 | -- | -954.46 | -- | 45.12 | -- | -89.85 | -- | 0.7066 | -- | 2.14 | -- | -28.82 | -- | -616.14 | -- | -- | -- |
| BioRegenx Inc | 634.81k | -727.95k | 22.72m | 10.00 | -- | 0.894 | -- | 35.79 | -0.001 | -0.001 | 0.0016 | 0.0178 | 0.0617 | -- | -- | 63,481.00 | -7.07 | -- | -8.46 | -- | 74.90 | -- | -114.67 | -- | 0.1547 | -8.80 | 0.0977 | -- | -47.25 | -- | -629.37 | -- | -- | -- |
| bioAffinity Technologies Inc | 7.32m | -8.74m | 23.47m | 75.00 | -- | 6.89 | -- | 3.21 | -0.9007 | -0.9007 | 0.7439 | 0.2989 | 0.9422 | 236.81 | 8.68 | 97,545.07 | -112.51 | -- | -140.58 | -- | 35.47 | -- | -119.41 | -- | 1.14 | -296.51 | 0.234 | -- | 52,660.42 | -- | 2.66 | -- | -- | -- |
| IR-Med Inc | 0.00 | -3.47m | 24.05m | 6.00 | -- | 77.91 | -- | -- | -0.0499 | -0.0499 | 0.00 | 0.0051 | 0.00 | -- | -- | 0.00 | -197.95 | -- | -273.36 | -- | -- | -- | -- | -- | -- | -- | 0.3019 | -- | -- | -- | -3.70 | -- | -- | -- |
| Golden Valley Development Inc | 0.00 | -92.53k | 24.63m | 0.00 | -- | -- | -- | -- | -11.17 | -11.17 | 0.00 | -0.0211 | 0.00 | -- | -- | -- | -7,710.83 | -- | -- | -- | -- | -- | -- | -3,073.27 | -- | -3.96 | -- | -- | -- | -- | 45.48 | -- | -- | -- |
Data as of Sep 30 2024. Currency figures normalised to Renalytix PLC's reporting currency: US Dollar USD
10.53%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Jefferson River Capital LLCas of 19 Mar 2024 | 4.27m | 5.53% |
| Pinnacle Associates Ltd.as of 30 Jun 2024 | 815.43k | 1.06% |
| Gilder, Gagnon, Howe & Co. LLCas of 31 Mar 2024 | 761.11k | 0.99% |
| Stifel Nicolaus & Co., Inc. (Investment Management)as of 31 Mar 2024 | 557.40k | 0.72% |
| Levin Capital Strategies LPas of 30 Jun 2024 | 555.00k | 0.72% |
| Tejara Capital Ltd.as of 31 Mar 2024 | 500.39k | 0.65% |
| Corient Private Wealth LLCas of 31 Mar 2024 | 335.51k | 0.44% |
| Lazard Asset Management LLCas of 31 Mar 2024 | 125.48k | 0.16% |
| Nantahala Capital Management LLCas of 31 Mar 2024 | 117.64k | 0.15% |
| Ersel Gestion Internationale SA (United Kingdom)as of 31 Dec 2023 | 92.28k | 0.12% |
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
